| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.092 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.06 |